KALA BIO KALA Stock
KALA BIO Price Chart
KALA BIO KALA Financial and Trading Overview
| KALA BIO stock price | 2.24 USD |
| Previous Close | 2.23 USD |
| Open | 2.26 USD |
| Bid | 2.35 USD x 100 |
| Ask | 2.16 USD x 100 |
| Day's Range | 2.19 - 2.45 USD |
| 52 Week Range | 2.1 - 1030 USD |
| Volume | 100.06K USD |
| Avg. Volume | 171.57K USD |
| Market Cap | 40.9M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -102.01 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
KALA Valuation Measures
| Enterprise Value | 32.13M USD |
| Trailing P/E | N/A |
| Forward P/E | -0.3298351 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.17518714 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.967 |
Trading Information
KALA BIO Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -98.92% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 1030 USD |
| 52 Week Low | 2.1 USD |
| 50-Day Moving Average | 6.6 USD |
| 200-Day Moving Average | 130.08 USD |
KALA Share Statistics
| Avg. Volume (3 month) | 171.57K USD |
| Avg. Daily Volume (10-Days) | 72.77K USD |
| Shares Outstanding | 18.59M |
| Float | 18.59M |
| Short Ratio | 0.49 |
| % Held by Insiders | 1.29% |
| % Held by Institutions | 0.64% |
| Shares Short | 42.59K |
| Short % of Float | 0.22% |
| Short % of Shares Outstanding | 0.22% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:50 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -69.26% |
| Return on Equity (ttm) | -238.67% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -33234750 USD |
| Net Income Avi to Common (ttm) | -19654000 USD |
| Diluted EPS (ttm) | -102.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 8.76M USD |
| Total Cash Per Share (mrq) | 0.47 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 7.911 |
| Book Value Per Share (mrq) | 12.558 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -26062000 USD |
| Levered Free Cash Flow (ttm) | -19470500 USD |
Profile of KALA BIO
| Country | United States |
| State | MA |
| City | Arlington |
| Address | 1167 Massachusetts Avenue |
| ZIP | 02476 |
| Phone | 781 996 5252 |
| Website | https://www.kalarx.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 6 |
KALA BIO, Inc., a biopharmaceutical company, engages in the development of an on-premises artificial intelligence (AI) infrastructure platform for biotechnology research applications in the United States. The company develops Researgency, an agentic AI research platform for private enterprise AI deployment. Its platform intends to utilize the KPI-012 clinical development dataset as a proof-of-concept validation environment, as well as the mesenchymal stem cell secretome (MSC-S) and persistent corneal epithelial defects (PCED) research for agentic workflows on trial data. The company serves biotechnology and pharmaceutical companies. The company was formerly known as Kala Pharmaceuticals, Inc. and changed its name to KALA BIO, Inc. in August 2023. KALA BIO, Inc. was incorporated in 2009 and is headquartered in Arlington, Massachusetts.
Q&A For KALA BIO Stock
What is a current KALA stock price?
KALA BIO KALA stock price today per share is 2.24 USD.
How to purchase KALA BIO stock?
You can buy KALA shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for KALA BIO?
The stock symbol or ticker of KALA BIO is KALA.
Which industry does the KALA BIO company belong to?
The KALA BIO industry is Biotechnology.
How many shares does KALA BIO have in circulation?
The max supply of KALA BIO shares is 18.59M.
What is KALA BIO Price to Earnings Ratio (PE Ratio)?
KALA BIO PE Ratio is now.
What was KALA BIO earnings per share over the trailing 12 months (TTM)?
KALA BIO EPS is -102.01 USD over the trailing 12 months.
Which sector does the KALA BIO company belong to?
The KALA BIO sector is Healthcare.
KALA BIO KALA included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 26853.98 USD — |
-0.89
|
8.32B USD — | 26769.16 USD — | 27130.88 USD — | — - | 8.32B USD — |
| US Tech Global Select Market Com NQGS | 13180.97 USD — |
-0.87
|
— — | 13139.79 USD — | 13316.81 USD — | — - | — — |
| US Tech Health Care IXHC | 1133.51 USD — |
+1.54
|
— — | 1113.35 USD — | 1133.95 USD — | — - | — — |
- {{ link.label }} {{link}}